Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Ribupatide

A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects

Fujian Shengdi Pharmaceutical Co · Phase 3 · Recruiting · Enrollment 675

NCT07670884

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
HRS9531 Tablet Groupn/rn/rn/rn/rn/r
HRS9531 Tablet Placebo Groupn/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.